ProShare Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4K | Buy |
39,260
+2,014
| +5% | +$2.28K | ﹤0.01% | 2005 |
|
|
2025
Q1 | $54.4K | Sell |
37,246
-8,836
| -19% | -$12.9K | ﹤0.01% | 1943 |
|
|
2024
Q4 | $98.2K | Buy |
46,082
+9,388
| +26% | +$20K | ﹤0.01% | 2080 |
|
|
2024
Q3 | $103K | Buy |
36,694
+11,149
| +44% | +$31.2K | ﹤0.01% | 1878 |
|
|
2024
Q2 | $59.5K | Sell |
25,545
-3,224
| -11% | -$7.51K | ﹤0.01% | 1726 |
|
|
2024
Q1 | $129K | Buy |
28,769
+2,377
| +9% | +$10.6K | ﹤0.01% | 1780 |
|
|
2023
Q4 | $84.7K | Buy |
26,392
+4,759
| +22% | +$15.3K | ﹤0.01% | 1803 |
|
|
2023
Q3 | $68.6K | Buy |
21,633
+1,509
| +7% | +$4.78K | ﹤0.01% | 1687 |
|
|
2023
Q2 | $100K | Buy |
20,124
+726
| +4% | +$3.61K | ﹤0.01% | 1698 |
|
|
2023
Q1 | $95.8K | Sell |
19,398
-2,783
| -13% | -$13.7K | ﹤0.01% | 1599 |
|
|
2022
Q4 | $140K | Buy |
22,181
+1,297
| +6% | +$8.16K | ﹤0.01% | 1582 |
|
|
2022
Q3 | $225K | Sell |
20,884
-475
| -2% | -$5.12K | ﹤0.01% | 1332 |
|
|
2022
Q2 | $243K | Sell |
21,359
-7,862
| -27% | -$89.4K | ﹤0.01% | 1343 |
|
|
2022
Q1 | $266K | Sell |
29,221
-7,554
| -21% | -$68.8K | ﹤0.01% | 1711 |
|
|
2021
Q4 | $549K | Sell |
36,775
-4,062
| -10% | -$60.6K | ﹤0.01% | 1378 |
|
|
2021
Q3 | $1.05M | Sell |
40,837
-4,639
| -10% | -$119K | ﹤0.01% | 891 |
|
|
2021
Q2 | $1.19M | Buy |
45,476
+10,365
| +30% | +$270K | ﹤0.01% | 936 |
|
|
2021
Q1 | $1.24M | Buy |
35,111
+332
| +1% | +$11.7K | ﹤0.01% | 877 |
|
|
2020
Q4 | $878K | Buy |
34,779
+4,627
| +15% | +$117K | ﹤0.01% | 944 |
|
|
2020
Q3 | $1.14M | Buy |
30,152
+2,493
| +9% | +$94K | 0.01% | 688 |
|
|
2020
Q2 | $1.18M | Buy |
27,659
+7,667
| +38% | +$328K | 0.01% | 664 |
|
|
2020
Q1 | $389K | Sell |
19,992
-12,850
| -39% | -$250K | ﹤0.01% | 796 |
|
|
2019
Q4 | $853K | Buy |
+32,842
| New | +$853K | ﹤0.01% | 851 |
|